International CRO

Cromos pharma: international CRO

Cromos Pharma: International CRO

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Learn more
No Patients No Payment

No Patients
No Payment

No Patients
No Payment

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

Learn more
Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

Learn more
New Cromos Pharma's office in Portugal

New Office
in Portugal

New Office
in Portugal

We are thrilled to announce that Cromos Pharma is opening a new office in Portugal!

We are thrilled to announce that Cromos Pharma is opening a new office in Portugal!

Learn more
Clinical Research Focus 34th edition | Cromos Pharma

Clinical research focus. 34th edition

Clinical research focus. 34th edition

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Learn more
Deep dive into Clinical Trials Specifics in Türkiye | Cromos Pharma

Clinical Trials Specifics in Türkiye

Clinical Trials Specifics in Türkiye

Discover why Türkiye should be considered for the next clinical research venture.

Discover why Türkiye should be considered for the next clinical research venture.

Learn more
Cromos Pharma: International CRO No Patients
No Payment
 Free Multicountry Feasibility Report New Office
in Portugal Clinical research focus. 34th edition Clinical Trials Specifics in Türkiye
Meet Cromos Pharma
Meet Cromos Pharma at the 66th ASH Annual Meeting and Exposition
7-10 Dec 2024
San Diego, CA
Cromos Pharma at the 42nd Annual J.P. Morgan
13-15 Jan 2025
San Francisco, CA
SCOPE Summit | Cromos Pharma
3-6 Feb 2025
Orlando, FL
Contact us

why cromos pharma

Cromos Pharma is a US based international contract research organization (CRO) delivering integrated clinical research solutions that accelerate drug development.

Icon, clinical trials in central & easter europe
350 clinical trials conducted in 70+ indications
Icon, clinical trials in central & easter europe
120,000+ patients enrolled across 3,500 trial sites
Icon, clinical trials in central & easter europe
20+ operating countries with in-depth local expertise
Learn more

What we do

Icon, clinical trials in central & easter europe
Patient recruitment
Patient recruitment
  • Promotional and educational materials
  • DTC outreach
  • Investigator’s materials
  • Booster visits
  • Referral sites
  • Commitment to patients
  • Patient’s materials
Icon, clinical trials in central & easter europe
Clinical Research Services
Clinical Research Services
  • Capability and Feasibility Assessment
  • Project Management
  • Monitoring Services
Icon, clinical trials in central & easter europe
Regulatory
Services
Regulatory Services
  • Compilation of initial documents for RA and ECs/IRBs
  • Review of IC documentation
  • Obtaining of trial subjects’ insurance
  • Secure import/export licenses
  • Regional regulatory consultation
  • Regulatory strategy and clinical development planning
  • Submissions to Regulatory Agencies
icon - eu legal services
EU legal representation
EU legal representation
  • Your clinical gateway to Europe
  • Legal representation in EU/EEA
  • QP Statement obtainment
  • Cost-effective and time-saving services
Icon, clinical trials in central & easter europe
Medical
Writing
Medical Writing
  • Study concepts and outlines
  • Clinical study protocols and amendments
  • SAP for inclusion into protocol
  • Investigator Brochures
  • Investigational Medicinal Product Dossiers
  • Patient Informed Consent Forms
  • Clinical Study Reports
  • Executive summaries for efficacy or safety, ISS, ISE
  • Reviews of clinical and nonclinical data
  • Patient narratives, SAE narratives
  • Abstracts, posters, and journal articles
Icon, clinical trials in central & easter europe
Biostatistics
and data
management
Data Management
  • CRF development/validation
  • Customized database design/validation
  • Data entry screen design/validation
  • Double data entry
  • Programming under SAS
  • Data validation
  • Data listings
  • Convenient data format for the client
  • Data transfers
  • Data coding
Icon, clinical trials in central & easter europe
CTM
Logitics
CTM Logitics
  • Full Scope of Clinical Trial Logistics Services
  • Controlled access to storage areas
  • 24/7 receipt of IMP and CTM
  • Patented warehouse database program
  • General liability and property insurances
  • Compliance with ISO 9001:2015 & GDP
Icon, clinical trials in central & easter europe
PV
Support
PV Support
  • Therapeutic, technical, and operational excellence
  • Tailored and cost-effective safety solutions
  • Flexible outsourcing of safety functions
  • A team of QPPVs for registered products in EU
  • Updated country-specific regulatory requirements
  • Robust quality system
  • Pharmacovigilance consultancy
Icon, clinical trials in central & easter europe
Independent
Audits
Independent Audits
  • Clinical site GCP audits
  • Documentary Trial Master File audits
  • System Vendor Audits
  • Regulatory Inspection and Sponsor’s audit readiness check

No patients No payment

We are the only CRO that offers a unique risk sharing program, “No Patients – No Payment”, which means that when we don’t recruit, you don’t pay.

Learn more
1. Пилот, разборы, ответы и лайвы

No patients No payment

insights

News

Celebrating 20 years of success | Cromos Pharma
Celebrating 20 Years of Success with Cromos Pharma
We proudly celebrate 20 years of dedication, innovation, and growth. It’s been an incredible journey, and we’re grateful for the trust and support of our clients, partners, and team members who have been part of this path. From our humble beginnings to becoming a trusted name in clinical research, we’ve achieved so much together, and there’s still so much more ahead!               Here’s a glimpse of some of the key moments and key people who have helped shape our...
Read more
New Cromos Pharma's office in Portugal
New Cromos Pharma’s Office in Portugal
We are thrilled to announce that Cromos Pharma is opening a new office in Portugal!  This expansion strengthens our presence in Southern Europe, enhancing our ability to deliver high-quality clinical research services across the...
Read more
Happy Labor Day 2024 | Cromos Pharma
Happy Labor Day 2024
Labor Day is a time to celebrate the hard work and dedication of workers everywhere. It’s a chance to relax, recharge, and enjoy the rewards of your efforts. From everyone at Cromos Pharma, we wish you a joyful Labor Day! May your day be filled with rest, joy, and quality moments with your loved ones. Use this time to refresh and prepare for the exciting opportunities...
Read more
Strategic Alliance: Syngene + Cromos Pharma
Expanding Horizons: “Syngene – Cromos Pharma” Alliance Transforms Clinical Research
We’re thrilled to announce our strategic alliance with Syngene! This partnership combines our expertise in offering high-quality execution and global coverage for clinical trials.  Together, we simplify patient recruitment across the US, Europe, and India, while providing comprehensive clinical development services. Superior project management ensures seamless execution of global trials and unified project...
Read more
Happy Bastille Day from Cromos Pharma
Happy Bastille Day from Cromos Pharma!
We join in celebrating French culture and history. Enjoy the festivities and have a wonderful...
Read more
Happy Independence Day 2024 | Cromos Pharma
Happy Independence Day 2024
Happy 4th of July from all of us at Cromos Pharma! As we celebrate Independence Day, we reflect on the values of freedom and innovation that inspire our work every day. Wishing everyone a safe and joyous holiday filled with celebration and...
Read more

Events

Cromos Pharma at the 9th annual conference of the Hungarian Clinical Trial Management Society 2024
Cromos Pharma’s Monika David Shares Key Insights at Hungarian Clinical Trials Conference
On September 19-20, 2024, the ninth annual conference of the Hungarian Clinical Trial Management Society took place in Siófok, Hungary. The event brought together industry professionals to discuss significant developments in clinical research, including the Clinical Trials Information System (CTIS), new regulations, and the evolving role of institutional pharmacies in clinical trials.  Monika David, EU Regulatory Lead at Cromos Pharma, presented on “EU CTR: Results and Experiences of the Last...
Read more
Vlad Bogin at the Morgan Stanley 22nd Annual Global Healthcare Conference | Cromos Pharma
Vlad Bogin at the Morgan Stanley 22nd Annual Global Healthcare Conference
Vlad Bogin, MD, FACP, CEO of Cromos Pharma, attended the Morgan Stanley 22nd Annual Global Healthcare Conference in New York last week. It was a valuable opportunity to engage with industry leaders, exchange insights, share expertise, and contribute to shaping the trends that drive innovation and strategic practices in...
Read more
Maaet Vlad Bogin at Morgan Stanley 22nd Annual Global Healthcare Conference 2024 in New York | Cromos Pharma
Meet Vlad Bogin at Morgan Stanley 22nd Annual Global Healthcare Conference 2024
We are thrilled to announce that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending the Morgan Stanley 22nd Annual Global Healthcare Conference from September 4-6, 2024, in New York, NY. Dr. Bogin is excited to participate in this esteemed gathering of healthcare experts, where he plans to connect with colleagues, exchange knowledge, and stay abreast of cutting-edge developments in healthcare. The conference will delve into financial frameworks and opportunities for investment in...
Read more
Cromos Pharma’s Türkiye Country Head Speaks at Biruni University Event in Istanbul
Cromos Pharma’s Türkiye Country Head Speaks at Biruni University Event in Istanbul
We are pleased to announce that Seniz Sagol, Cromos Pharma’s Country Head for Türkiye, was among the speakers at a significant industry event organized by Biruni University Medical Faculty in Istanbul this week. The GCP Training, endorsed by the Ministry of Health, aimed to elevate industry standards and practices. Seniz contributed with two sessions titled “Clinical Trial Protocol” and “Terminology in Clinical Research,” providing valuable insights into critical aspects of clinical...
Read more
Meet Cromos Pharma at the BIO International Convention 2024
Meet us at the BIO International Convention 2024
Cromos Pharma’s US Business Development Director Nicole Brenna is excited to participate in the BIO International Convention, set for June 3-6, 2024, at the Convention Center in San Diego, California. This event consistently features insightful presentations from top pharma and biotech leaders. We are eager to share our expertise in clinical trial management and discuss how our solutions can expedite the drug development process. To arrange a meeting and discuss your clinical programs, please...
Read more
Meet Vlad Bogin at the ASCO Annual Meeting 2024 | Cromos Pharma
Meet Vlad Bogin at ASCO 2024
The CEO of Cromos Pharma, Vlad Bogin, MD, FACP, is attending the ASCO Conference, scheduled from May 31 to June 4 in Chicago, IL. This prestigious event gathers leading professionals in oncology, and Dr. Bogin is eager to engage with peers, share insights, and explore the latest innovations in cancer treatment and research. To schedule a meeting with Dr. Bogin during the conference or to learn more about our capabilities, please reach out to us at...
Read more

Publications

Lung Cancer Care: New Treatment Insights | Cromos Pharma
Advancing Lung Cancer Care: New Treatment Insights Highlighted During Awareness Month
As Lung Cancer Awareness Month brings attention to the disease, the impact of lung cancer worldwide remains grave, with around 1.8 million lives lost each year. Recent findings in cancer research bring encouraging news: a new combination therapy of amivantamab and lazertinib offers a substantial improvement for those with advanced non-small cell lung cancer (NSCLC). This innovative treatment has shown to extend progression-free survival significantly compared to standard options, marking a...
Read more
World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment | Cromos Pharma
World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment
Key takeaways:  GLP-1 Agonists and SGLT2 Inhibitors are two effective medication classes for managing Type 2 diabetes, each offering unique benefits.  GLP-1 Agonists (e.g., Ozempic) provide significant blood sugar control and weight loss, ideal for patients prioritizing weight management.  SGLT2 Inhibitors (e.g., Jardiance) offer strong heart and kidney protection, often recommended for patients with heart failure or chronic kidney disease.  Combination Therapy of GLP-1 agonists and SGLT2...
Read more
Changing Defibrillator Pad Placement Increase Survival by 164% | Cromos Pharma
Changing Defibrillator Pad Placement Increases Survival by 164%
A recent trial has revealed that placing defibrillator pads in an anterior-posterior (AP) configuration—on the chest and back—can increase the odds of surviving an out-of-hospital cardiac arrest (OHCA) by more than two-and-a-half times compared to the traditional anterior-lateral (AL) positioning, where both pads are placed on the chest. These findings offer a significant advancement in improving the survival chances for patients experiencing shockable heart rhythms like ventricular...
Read more
Stem Cells Therapy Offers New Hope for Type 1 Diabetes | Cromos Pharma
Groundbreaking Stem Cell Therapy Offers New Hope for Type 1 Diabetes: A Medical Breakthrough
In a world-first, researchers have successfully reversed type 1 diabetes in a patient using stem cell therapy, marking a potential turning point in the treatment of this chronic condition. This groundbreaking work, led by Chinese scientists, represents a shift from managing diabetes to potentially curing it—a development that could bring renewed hope to millions of people worldwide. A New Approach to Type 1 Diabetes Treatment Researchers at Peking University achieved this remarkable feat in a...
Read more
How the EU CTR is Shaping the Future of Clinical Trials | Cromos Pharma
How the EU CTR is Shaping the Future of Clinical Trials: Insights and Key Challenges for Sponsors
The landscape of clinical trials in the EU has undergone a significant transformation with the implementation of the EU Clinical Trials Regulation (CTR). While this regulation promises a more streamlined and transparent approach, it also presents new challenges for sponsors, particularly around managing transparency obligations, navigating complex regulatory processes, and ensuring compliance under the harmonized system. These challenges are especially pronounced for sponsors who may lack the...
Read more
Data Protection Representative: Understanding GDPR's Article 27 Requirement | Cromos Pharma
Do You Need a Data Protection Representative? Understanding GDPR’s Article 27 Requirement
Key Takeaways: When is a DPR Required?: Non-EU companies processing data of EU residents are required to appoint a DPR under Article 27 of the GDPR. DPR’s Responsibilities: The DPR facilitates communication between non-EU companies, EU data subjects, and regulatory authorities. Consequences of Non-Compliance: Failure to appoint a DPR when necessary can result in penalties, including fines of up to €10 million or 2% of global revenue. For biotech companies and drug developers operating within...
Read more

Videos

1. Пилот, разборы, ответы и лайвы
Cromos Pharma’s 20th Anniversary
1. Пилот, разборы, ответы и лайвы
CEO Insights Podcast: Interview with Vlad Bogin
1. Пилот, разборы, ответы и лайвы
Cromos Pharma’s “No Patients – No Payment” program explained
1. Пилот, разборы, ответы и лайвы
Revolutionizing the landscape for small-cap, development-stage life science companies.
1. Пилот, разборы, ответы и лайвы
Deep dive into Clinical Trials Specifics in Türkiye
1. Пилот, разборы, ответы и лайвы
The Invaluable Role of Explainer Videos